# Bhagiradha Chemicals & Industries share price today (Bhagiradha Chemicals & Industries Ltd, NSE: BHAGCHEM)

> Bhagiradha Chemicals & Industries share price today: ₹187.19 at the NSE close on 3 November 2026, down 24.2% in a year. Bhagiradha Chemicals & Industries (NSE: BHAGCHEM) is worth ₹2,432 crore, trades at a P/E of 88.3 and has closed between ₹180.15 and ₹295.65 over the past 52 weeks. > Bhagiradha Chemicals & Industries Ltd's earnings have grown faster than its share price. Earnings per share grew +30.8% in a year while the price moved −24.2%. BHAGCHEM · Pesticides/Agrochemicals · data as of 3 November 2026. Page: https://www.sectoralpha.in/stocks/bhagiradha-chemicals-industries-ltd

Sector Alpha also publishes a daily newsletter that explains one Indian stock at a time: https://newsletter.sectoralpha.in/?utm_source=sectoralpha&utm_medium=ai_text&utm_campaign=llms

## Key numbers

- Business trend: Mixed, from the last 12 quarters
- Price: ₹187.19 (−24.2% in a year)
- P/E: 88.3× (higher than 53% of the last 6 years)
- Revenue (Jun 2026): ₹195 Cr (+57.3% on a year ago)
- Profit (Jun 2026): ₹13.0 Cr (+225.0% on a year ago)
- Operating margin: 16.0% (+9.0 points on a year ago)
- ROCE: 5%, FY26
- ROIC: 4.5%, against a 12.0% cost of capital: −7.5 points

The main question: profits are rising, but only −14% of the last 3 years' profit came in as cash from operations. The gap between reported profit and actual cash is the thing to watch. ## What is the Bhagiradha Chemicals & Industries share price today? Bhagiradha Chemicals & Industries Ltd's share price was ₹187.19 at the close on 3 November 2026. It has been falling for 2 weeks. That is 24.8% below its average price over the last 200 trading days. Over the past 13 weeks it has done worse than the NIFTY 500, and it has been behind for 10 weeks running. In the last 52 weeks it traded between ₹180 and ₹296, and at that close it sat 6% of the way up from that low. Over the last 11 years the share price moved +2,322% while the NIFTY 500 moved +257%, so it is ahead of the index over that whole period. It was last ahead over 13 weeks in the week of 28 August 2026. The chart above shows the 13-week comparison for every week. This page treats a rise as over when the price closes below its 200-day average on two Fridays in a row. ## What changed at Bhagiradha Chemicals & Industries this quarter? 1. Best operating margin in 15 quarters Operating margin was 16% in the June 2026 quarter, against 7% a year earlier. 3. Revenue up on a year earlier for 7 quarters in a row In the June 2026 quarter revenue was ₹195 crore, +57.3% on a year earlier. ## What are Bhagiradha Chemicals & Industries' latest quarterly results? For April to June 2026 (the quarter ended 30 June 2026), Bhagiradha Chemicals & Industries reported revenue of ₹195 crore, up 57.3% from ₹124 crore a year earlier, and a profit of ₹13.0 crore, up 225.0% from ₹4.00 crore. ### Bhagiradha Chemicals & Industries results: April to June 2026 against a year earlier

| Measure | April to June 2026 | April to June 2025 | Change |
| --- | --- | --- | --- |
| Revenue | ₹195 crore | ₹124 crore | +57.3% |
| Profit | ₹13.0 crore | ₹4.00 crore | +225.0% |
| Earnings per share | ₹1.03 | ₹0.31 | +232.3% |
| Operating margin | 16.0% | 7.0% | +9.0 points |

The next results, for July to September 2026, are due by 14 November 2026: listed companies must publish quarterly results within 45 days of the quarter's end (60 days for the January to March quarter). (From the company's reported quarterly results (quarter ended 30 June 2026). Revenue and profit in ₹ crore.)

## What is the Bhagiradha Chemicals & Industries share price history? Bhagiradha Chemicals & Industries closed at ₹187.19 on 3 November 2026, down 24.2% from ₹247.10 a year earlier (31 October 2025) and up 155.7% over five years. Its highest weekly close since February 2016 was ₹414.55 on 23 August 2024. ### Bhagiradha Chemicals & Industries share price: then and now

| When | Close | Change to 3 Nov 2026 |
| --- | --- | --- |
| 1 week ago · 23 Oct 2026 | ₹195.70 | −4.3% |
| 1 month ago · 1 Oct 2026 | ₹235.05 | −20.4% |
| 6 months ago · 30 Apr 2026 | ₹266.25 | −29.7% |
| 1 year ago · 31 Oct 2025 | ₹247.10 | −24.2% |
| 3 years ago · 3 Nov 2023 | ₹151.03 | +23.9% |
| 5 years ago · 4 Nov 2021 | ₹73.20 | +155.7% |
| 10 years ago · 4 Nov 2016 | ₹13.23 | +1,314.9% |
| Earliest and lowest weekly close in our records · 26 Feb 2016 | ₹7.73 | +2,321.6% |
| Highest weekly close since February 2016 · 23 Aug 2024 | ₹414.55 | −54.8% |
| 52-week high (weekly close) · 10 Jul 2026 | ₹295.65 | −36.7% |
| 52-week low (weekly close) · 20 Mar 2026 | ₹180.15 | +3.9% |

Weekly closing prices, adjusted for splits and bonuses so every price is on today’s share count. Each change is the move from that price to the 3 Nov 2026 close. A day's intraday high or low can go beyond these weekly closes. (564 weekly closes from 26 February 2016 to 3 November 2026.)

## What is the latest news on Bhagiradha Chemicals & Industries? 3 Nov 2026: Bhagiradha Chemicals & Industries closed at ₹187.19, down 4.3% on the week and down 20.4% on the month. 23 Jul 2026: ex-date for a dividend of ₹0.15 a share. ### Earlier

- Results for April to June 2026: Revenue up 57.3% and profit up 225.0% on a year earlier. - 2 May 2024: Share split: face value cut from ₹10 to ₹1 a share (ex-date). ## What dividend does Bhagiradha Chemicals & Industries pay? Bhagiradha Chemicals & Industries paid ₹0.15 a share in regular dividends in the 12 months to 4 November 2026 (1 payment), a yield of 0.08% at the ₹187.19 close on 3 November 2026. The last was a dividend of ₹0.15 a share, ex-date 23 July 2026. ### Bhagiradha Chemicals & Industries dividends since 1 April 2021

| Ex-date | Dividend per share | Type | Record date |
| --- | --- | --- | --- |
| 23 Jul 2026 | ₹0.15 | Dividend | same day |
| 14 Aug 2025 | ₹0.15 | Dividend | same day |
| 2 Aug 2024 | ₹0.10 | Dividend | n/a |
| 27 Jul 2023 | ₹3 | Dividend | n/a |
| 16 Nov 2022 | ₹1 | Interim | 17 Nov 2022 |
| 4 Aug 2022 | ₹2 | Dividend | n/a |
| 11 Nov 2021 | ₹1 | Interim | 12 Nov 2021 |

Amounts as the company declared them on the NSE. A dividend goes to whoever owns the shares before the ex-date. 5 of 5 Of the last 5 financial years, years with an NSE dividend record

Yes. Bhagiradha Chemicals & Industries Ltd paid out 11% of its profit as dividends in FY26, and it paid a dividend in 5 of its last 7 reported years. (From the NSE corporate-actions record, read 4 November 2026.)

## Which stock lists is Bhagiradha Chemicals & Industries on? Bhagiradha Chemicals & Industries is not on any of our India lists this week. ## Is Bhagiradha Chemicals & Industries profitable? Bhagiradha Chemicals & Industries Ltd earned ₹13.0 Cr of net profit in the Jun 2026 quarter, +225.0% on the same quarter a year earlier. Full-year FY26 profit was ₹18.0 Cr. Over 6 years profit has grown 17.0% a year on average. That is 6.7% of the quarter's revenue. The same quarter a year earlier earned ₹4.0 Cr. 1 of the last 12 reported quarters were loss-making. For the full year, FY26 profit was ₹18.0 Cr (+28.6% on the year before). Why profit moved: revenue changed +57.3% on a year earlier and the margin moved +9.0 percentage points. Most of the change came from keeping more of each sale. On average over the last four quarters, profit changed +90.0% and revenue +32.8%. Profit is growing faster than sales: fixed costs are spread over more sales, so each extra rupee of revenue adds more to profit. ## How much revenue does Bhagiradha Chemicals & Industries make, and is it growing? Bhagiradha Chemicals & Industries Ltd reported ₹195 Cr of revenue in the Jun 2026 quarter, +57.3% on the same quarter a year earlier. That is the 7th quarter in a row with growth on the year before. Over 6 years it has grown 13.9% a year on average. The last full year, FY26, came in at ₹536 Cr. The last four reported quarters add to ₹607 Cr. FY26 revenue was ₹536 Cr, +21.8% on the year before. Recent pace: the last four quarters grew +32.8% on average, against 13.9% a year over the longer run, so this year is growing faster than its own long-run rate. Is growth speeding up? Revenue over the last 12 months grew +33.7%, against +20.5% a year over the last 8 quarters (accelerating); profit over the last 12 months grew +133.3%, against +12.8% a year (accelerating). ## How much of every ₹100 of sales does Bhagiradha Chemicals & Industries keep? Bhagiradha Chemicals & Industries Ltd's operating margin was 16.0% in the Jun 2026 quarter, 9.0 percentage points higher than the same quarter a year ago. Across 7 years it has been between 7.0% and 16.0%. The latest quarter is within that range. Why the margin moved: operating margin changed +8.4 percentage points on the year while gross margin changed +5.0 points. So the gain came mostly from costs below the gross margin, such as staff and overheads, measured against sales. ## Is Bhagiradha Chemicals & Industries' profit turning into cash? Over the last 3 years Bhagiradha Chemicals & Industries Ltd's operations used more cash than they brought in, so cash conversion was −14%, a gap worth watching. In FY26 it brought in ₹12.0 Cr of operating cash against ₹18.0 Cr of profit. After ₹163 Cr of spending on assets, free cash was −₹151 Cr: it spent more than its operations brought in. Cash-flow figures here are yearly, because quarterly cash statements are not published, so this section changes once a year. Why −14% of profit came in as cash: the cash cycle got 72 days longer between FY21 and FY26, so more of each rupee of profit waits in the business before it arrives. When less than 70% of profit comes in as cash, it is the thing to watch on this page. What to look at next: less of the profit turns into cash than it should, and the cash cycle is 72 days longer. The next section looks at where the cash is stuck. ## Where does Bhagiradha Chemicals & Industries' cash go? Bhagiradha Chemicals & Industries Ltd's cash cycle, the days between paying suppliers and getting paid by customers, was 148 days in FY26, up from 76 days in FY21. It spent ₹521 Cr on assets over the last 3 years. Customers take 139 days to pay, and stock sits for 161 days on average. At FY26 sales of ₹536 Cr, each day of that cycle ties up about ₹1.5 Cr, so roughly ₹217 Cr is tied up in the business at any time. FY26: customers took 139 days to pay and stock sat for 161 days, about 5.3 months of sales sitting as stock, for a full cycle of 148 days, longer than FY21's 76. The full loop: cash goes out to suppliers and production on day 0. Stock sits for 161 days. Customers pay about 139 days after that. Suppliers are paid at 152 days. Together that makes the 148-day cycle. Spending on assets: ₹521 Cr over the last 3 years, against ₹46.0 Cr of depreciation (the yearly wear and tear on existing assets). So it is building well beyond replacing what wears out. Work still in progress is ₹96.0 Cr (FY26): assets paid for that are not earning yet. In short: cash is getting stuck in the daily cycle, so watch the cycle more than the profit. ## What is Bhagiradha Chemicals & Industries' P/E ratio, and how does it compare with its own history? Bhagiradha Chemicals & Industries Ltd's P/E is 88.3×, in the middle of its own history: higher than 53% of past readings. Its usual P/E (the middle reading) is 82.2×, over 6 years of weekly prices. This compares the share price with the company’s own past. It does not say what the business is worth. Why the multiple is where it is: over the past year earnings per share moved +30.8% while the price moved −24.2%. Earnings did better than the price, which pulled the multiple down within its own range. Where the price move came from: over 5 years the price moved +20.7% a year; about −4.6% a year came from earnings growth and about +25.3 percentage points from the multiple (the market paying more). The split is approximate (price return minus earnings growth). It shows how much of the move came from the market paying a different multiple. In short: the multiple is about average against its own past, so the earnings trend underneath matters more than the multiple. ## Is the Bhagiradha Chemicals & Industries business getting better or worse? Bhagiradha Chemicals & Industries Ltd's business is giving mixed signals. There is no clear direction across the growth lines, with ROCE rising at 7.1%; each line tells part of the story. This is based on 12 quarters of 4 measures. Why it matters: when the lines disagree, each line above matters more than any single label. ## How much does Bhagiradha Chemicals & Industries earn on its capital? Bhagiradha Chemicals & Industries Ltd earned a ROCE of 5% in FY26. Its return on capital used (ROIC) is 7.5 percentage points below its cost of capital, so growth here does not yet pay for the capital it uses. It comes from a 3.4% net margin and 0.48× asset turnover (sales divided by assets). Why the return is what it is (FY26): a 3.4% net margin × 0.48× asset turnover × 1.60× leverage (assets divided by equity) ≈ 2.6% on equity. The margin does its share; borrowing plays a small part, so this return is earned, not borrowed. The key test, return on capital used minus the cost of capital: 4.5% − 12.0% = −7.5 percentage points. The 12.0% is a standard assumption for the cost of capital in India, not an estimate for this company. Read the sign and size of the gap, not the decimals. Negative: growth at these returns loses value until returns improve. ## Does Bhagiradha Chemicals & Industries have too much debt? Bhagiradha Chemicals & Industries Ltd has total debt of ₹234 Cr against shareholder equity of ₹698 Cr as of Jun 2026, so its debt is 0.34× its equity. Year by year, that ratio went from 0.43 in FY22 to 0.34 in FY26. Keep that borrowing in mind when reading the returns on this page. ## What is the Bhagiradha Chemicals & Industries shareholding pattern? No group of Bhagiradha Chemicals & Industries Ltd's owners changed its stake by a full percentage point over the last two years. Foreign institutions moved −0.1 points over the same period, to 0.1%. This uses the four owner groups that companies report every quarter; nothing is guessed between filings. Over the last two years: Promoters: −0.7 points over 8 quarters, to 19.6%; Foreign institutions: −0.1 points over 8 quarters, to 0.1%; Domestic institutions: −0.1 points over 8 quarters, to 3.0%. Promoters own under 20%, so this is a widely owned company where institutions, not a family, have the most say. ## How far is Bhagiradha Chemicals & Industries from balance-sheet trouble? For Bhagiradha Chemicals & Industries Ltd, the Z-score is not available, so we say so rather than guess one. It estimates how far the balance sheet is from trouble; it is not a forecast of failure. The debt, cash-flow and return sections show the balance-sheet figures we do have, each with its own date. ## How does Bhagiradha Chemicals & Industries rank in its industry? 44.7 out of 100, rank 15 of 25 in Pesticides/Agrochemicals, with 96% of the evidence available. Bhagiradha Chemicals & Industries Ltd scores 44.7 out of 100 against the 25 companies it is compared with in Pesticides/Agrochemicals, ranking 15. Earnings are strong; relative strength in its sector is -4.9% and the one-year return is -20.8%. The four parts add up to the total exactly: 29.4 + 6.9 + 1.8 + 6.6 = 44.7. This is the same number shown on the industry page; it is worked out once for the whole group and read here. What would change it: The score would fall if profit growth turns negative or margins stop improving while the share price lags its sector. ## Which companies is Bhagiradha Chemicals & Industries compared with? Bhagiradha Chemicals & Industries ranks 15 of 25 Pesticides/Agrochemicals companies on the 4-Factor Sector Score, with 44.7 out of 100. 1. [Sharda Cropchem Ltd](https://www.sectoralpha.in/stocks/sharda-cropchem-ltd) SHARDACROP · basing · Most evidence points up · 100% evidence 71.8 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 28.5/35 · Revenue 17.3% · Profit 42.5% · Operating margin change 2 points · 100% evidence Capital efficiency 19.5/25 · ROCE 30.2% · Operating margin 16% · 100% evidence Valuation 19.2/20 · P/E 9.3× · PEG 0.3 · 100% evidence Relative strength 4.6/20 · Lead over its industry -14.3% · Lead over NIFTY 500 -22.1% · 1 year -23.1% · 100% evidence · 0 of 12 weeks ahead Exact sum: 28.5 + 19.5 + 19.2 + 4.6 = 71.8 · What this means: Earnings are strong; relative strength in its sector is -14.3% and the one-year return is -23.1%. 2. [Titan Biotech Ltd](https://www.sectoralpha.in/stocks/titan-biotech-ltd) turning · Most evidence points up · 83% evidence 70.4 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 28.1/35 · Revenue 31.8% · Profit 38.7% · Operating margin change 2 points · 83% evidence Capital efficiency 20.2/25 · ROCE 22.8% · Operating margin 21% · 95% evidence Valuation 5.4/20 · P/E 51.8× · PEG n/a · 50% evidence Relative strength 16.7/20 · Lead over its industry 38.3% · Lead over NIFTY 500 25.1% · 1 year 101.5% · 100% evidence · 4 of 12 weeks ahead Exact sum: 28.1 + 20.2 + 5.4 + 16.7 = 70.4 · What this means: Earnings, capital efficiency and relative strength all agree. The open questions are about management, upcoming events and risks. 3. [Bayer CropScience Ltd](https://www.sectoralpha.in/stocks/bayer-cropscience-ltd) BAYERCROP · quiet · Evidence leans up · 81% evidence 63.9 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 22.3/35 · Revenue -2.8% · Profit 23.8% · Operating margin change 2 points · 88% evidence Capital efficiency 19.6/25 · ROCE 29.1% · Operating margin 20% · 100% evidence Valuation 13.4/20 · P/E 20× · PEG 1.28 · 100% evidence Relative strength 8.6/20 · Lead over its industry n/a · Lead over NIFTY 500 -20.8% · 1 year -33.3% · 25% evidence · 0 of 12 weeks ahead Exact sum: 22.3 + 19.6 + 13.4 + 8.6 = 63.9 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 4. [Punjab Chemicals & Crop Protection Ltd](https://www.sectoralpha.in/stocks/punjab-chemicals-crop-protection-ltd) PUNJABCHEM · quiet · Evidence leans up · 81% evidence 63.6 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 24.3/35 · Revenue 8.2% · Profit 43.5% · Operating margin change 1 points · 88% evidence Capital efficiency 13.6/25 · ROCE 18.6% · Operating margin 12% · 100% evidence Valuation 15.9/20 · P/E 17.4× · PEG 0.33 · 100% evidence Relative strength 9.8/20 · Lead over its industry n/a · Lead over NIFTY 500 -9.4% · 1 year -36.4% · 25% evidence · 6 of 12 weeks ahead Exact sum: 24.3 + 13.6 + 15.9 + 9.8 = 63.6 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 5. [Dharmaj Crop Guard Ltd](https://www.sectoralpha.in/stocks/dharmaj-crop-guard-ltd) DHARMAJ · losing its lead · Evidence leans up · 81% evidence 63.2 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 18.8/35 · Revenue 8.7% · Profit 13.2% · Operating margin change 1 points · 88% evidence Capital efficiency 14.7/25 · ROCE 16.8% · Operating margin 15% · 100% evidence Valuation 17.5/20 · P/E 14.3× · PEG 0.38 · 100% evidence Relative strength 12.2/20 · Lead over its industry n/a · Lead over NIFTY 500 4.7% · 1 year -9.9% · 25% evidence · 3 of 12 weeks ahead Exact sum: 18.8 + 14.7 + 17.5 + 12.2 = 63.2 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 6. [India Pesticides Ltd](https://www.sectoralpha.in/stocks/india-pesticides-ltd) IPL · quiet · Evidence leans up · 81% evidence 59.4 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 17.6/35 · Revenue 17% · Profit 10.1% · Operating margin change -2 points · 88% evidence Capital efficiency 15.4/25 · ROCE 16.6% · Operating margin 14% · 100% evidence Valuation 18.2/20 · P/E 12× · PEG 0.36 · 100% evidence Relative strength 8.2/20 · Lead over its industry n/a · Lead over NIFTY 500 -23% · 1 year -40.7% · 25% evidence · 0 of 12 weeks ahead Exact sum: 17.6 + 15.4 + 18.2 + 8.2 = 59.4 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 7. [Advance Agrolife Ltd](https://www.sectoralpha.in/stocks/advance-agrolife-ltd) ADVANCE · breaking out · Evidence leans up · 64% evidence 58.9 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 22.1/35 · Revenue 48.4% · Profit 81.5% · Operating margin change 1 points · 88% evidence Capital efficiency 14.1/25 · ROCE 19.6% · Operating margin 11% · 100% evidence Valuation 10.3/20 · P/E 16.3× · PEG n/a · 15% evidence Relative strength 12.4/20 · Lead over its industry n/a · Lead over NIFTY 500 10.6% · 1 year -8.6% · 25% evidence · 12 of 12 weeks ahead Exact sum: 22.1 + 14.1 + 10.3 + 12.4 = 58.9 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 8. [Dhanuka Agritech Ltd](https://www.sectoralpha.in/stocks/dhanuka-agritech-ltd) DHANUKA · turning · Evidence leans up · 100% evidence 57.0 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 10.8/35 · Revenue 0% · Profit 0.7% · Operating margin change 0 points · 100% evidence Capital efficiency 19.6/25 · ROCE 25.9% · Operating margin 23% · 100% evidence Valuation 9.2/20 · P/E 14.4× · PEG 2.27 · 100% evidence Relative strength 17.4/20 · Lead over its industry 7.1% · Lead over NIFTY 500 -2.8% · 1 year -28.7% · 100% evidence · 0 of 12 weeks ahead Exact sum: 10.8 + 19.6 + 9.2 + 17.4 = 57 · What this means: Relative strength against the index is -2.8%, and revenue and profit growth are weak. 9. [Jubilant Ingrevia Ltd](https://www.sectoralpha.in/stocks/jubilant-ingrevia-ltd) JUBLINGREA · quiet · Evidence leans up · 93% evidence 54.7 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 26.0/35 · Revenue 15.4% · Profit 21.9% · Operating margin change 3 points · 100% evidence Capital efficiency 13.6/25 · ROCE 11.4% · Operating margin 15% · 100% evidence Valuation 6.7/20 · P/E 24.7× · PEG 2.26 · 65% evidence Relative strength 8.4/20 · Lead over its industry -2.6% · Lead over NIFTY 500 -11.7% · 1 year -19.1% · 100% evidence · 3 of 12 weeks ahead Exact sum: 26 + 13.6 + 6.7 + 8.4 = 54.7 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 10. [Meghmani Organics Ltd](https://www.sectoralpha.in/stocks/meghmani-organics-ltd) MOL · breaking out · Evidence leans up · 64% evidence 52.1 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 22.0/35 · Revenue -7.8% · Profit 100% · Operating margin change 7 points · 88% evidence Capital efficiency 9.5/25 · ROCE 6.7% · Operating margin 18% · 100% evidence Valuation 9.6/20 · P/E 20.8× · PEG n/a · 15% evidence Relative strength 11.0/20 · Lead over its industry n/a · Lead over NIFTY 500 -0.5% · 1 year -35% · 25% evidence · 11 of 12 weeks ahead Exact sum: 22 + 9.5 + 9.6 + 11 = 52.1 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 11. [GSP Crop Science Ltd](https://www.sectoralpha.in/stocks/gsp-crop-science-ltd) GSPCROP · quiet · Too little evidence to rank firmly · 59% evidence 51.0 out of 100 Growth Capital Valuation Relative
12. [Epigral Ltd](https://www.sectoralpha.in/stocks/epigral-ltd) EPIGRAL · quiet · Evidence leans down · 81% evidence 49.6 out of 100 Growth Capital Valuation Relative
13. [Rallis India Ltd](https://www.sectoralpha.in/stocks/rallis-india-ltd) RALLIS · quiet · Evidence leans down · 85% evidence 48.4 out of 100 Growth Capital Valuation Relative
14. [Bharat Rasayan Ltd](https://www.sectoralpha.in/stocks/bharat-rasayan-ltd) BHARATRAS · quiet · Evidence leans down · 96% evidence 45.3 out of 100 Growth Capital Valuation Relative
15. Bhagiradha Chemicals & Industries Ltd this page BHAGCHEM · quiet · Evidence leans down · 96% evidence 44.7 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 29.4/35 · Revenue 33.7% · Profit 100% · Operating margin change 9 points · 88% evidence Capital efficiency 6.9/25 · ROCE 4.5% · Operating margin 16% · 100% evidence Valuation 1.8/20 · P/E 92× · PEG 8.06 · 100% evidence Relative strength 6.6/20 · Lead over its industry -4.9% · Lead over NIFTY 500 -13.9% · 1 year -20.8% · 100% evidence · 4 of 12 weeks ahead Exact sum: 29.4 + 6.9 + 1.8 + 6.6 = 44.7 · What this means: Earnings are strong; relative strength in its sector is -4.9% and the one-year return is -20.8%. 16. [Shivalik Rasayan Ltd](https://www.sectoralpha.in/stocks/shivalik-rasayan-ltd) SHIVALIK · Evidence leans down · 63% evidence 43.9 out of 100 Growth Capital Valuation Relative
17. [Excel Industries Ltd](https://www.sectoralpha.in/stocks/excel-industries-ltd) EXCELINDUS · quiet · Evidence leans down · 64% evidence 42.7 out of 100 Growth Capital Valuation Relative
18. [NACL Industries Ltd](https://www.sectoralpha.in/stocks/nacl-industries-ltd) NACLIND · basing · Evidence leans down · 96% evidence 42.0 out of 100 Growth Capital Valuation Relative
19. [Best Agrolife Ltd](https://www.sectoralpha.in/stocks/best-agrolife-ltd) BESTAGRO · quiet · Evidence leans down · 90% evidence 42.0 out of 100 Growth Capital Valuation Relative
20. [Sumitomo Chemical India Ltd](https://www.sectoralpha.in/stocks/sumitomo-chemical-india-ltd) SUMICHEM · quiet · Evidence leans down · 85% evidence 41.7 out of 100 Growth Capital Valuation Relative
21. [UPL Ltd](https://www.sectoralpha.in/stocks/upl-ltd) UPL · basing · Evidence leans down · 71% evidence 41.5 out of 100 Growth Capital Valuation Relative
22. [Insecticides India Ltd](https://www.sectoralpha.in/stocks/insecticides-india-ltd) INSECTICID · quiet · Evidence leans down · 96% evidence 40.5 out of 100 Growth Capital Valuation Relative
23. [P I Industries Ltd](https://www.sectoralpha.in/stocks/p-i-industries-ltd) PIIND · quiet · Evidence leans down · 81% evidence 38.3 out of 100 Growth Capital Valuation Relative
24. [Astec Lifesciences Ltd](https://www.sectoralpha.in/stocks/astec-lifesciences-ltd) ASTEC · quiet · Most evidence points down · 71% evidence 32.7 out of 100 Growth Capital Valuation Relative
25. [Heranba Industries Ltd](https://www.sectoralpha.in/stocks/heranba-industries-ltd) HERANBA · quiet · Most evidence points down · 76% evidence 29.9 out of 100 Growth Capital Valuation Relative

Missing figures are not scored as bad. They lower the confidence and pull the final score toward the middle. Relative strength counts only when the company has a reading for this week; with no reading, that factor is left out and its 20 points are shared across the other three in proportion. PEG is not shown when the ratio cannot mean anything: the company must be making a profit, its price-to-earnings must be positive, and its three-year earnings growth must fall between 5% and 60%. Dividing a price multiple by a loss, or by growth measured off a tiny base, produces a number that looks precise and tells you nothing. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led NIFTY 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step path the industry is placed on (basing, turning, breaking out, leader, fading, asleep), read from how many weeks running it has led NIFTY 500 and whether that lead is growing or shrinking. It describes where the share price stands, not the direction of earnings, and it is not a recommendation; it is left blank for a company whose weekly history is too short or too stale to read. The figures in this ranking come from the industry comparison: results through the Sep 2026 quarter, and the P/E at that quarter's end. The sections above use the latest weekly price, so a P/E or return there can differ a little from the one here. The stage words in this ranking (such as losing its lead or breaking out) describe the lead over the index, not the price phase in the price section. Related companies: [Pesticides/Agrochemicals](https://www.sectoralpha.in/sectors/pesticides-agrochemicals), all 25 compared on one page. ## Which companies are close to Bhagiradha Chemicals & Industries in size? Bhagiradha Chemicals & Industries is the 11th largest of 25 Pesticides/Agrochemicals companies on Sector Alpha by market value (scores of 30 October 2026). Just above it: Epigral, Rallis India and NACL Industries. Just below it: GSP Crop Science, Titan Biotech and Bharat Rasayan. ### Pesticides/Agrochemicals companies close in size

1. [Epigral Ltd](https://www.sectoralpha.in/stocks/epigral-ltd) ₹3,773 crore
2. [Rallis India Ltd](https://www.sectoralpha.in/stocks/rallis-india-ltd) ₹3,566 crore
3. [NACL Industries Ltd](https://www.sectoralpha.in/stocks/nacl-industries-ltd) ₹2,589 crore
4. Bhagiradha Chemicals & Industries Ltd ₹2,533 crore
5. [GSP Crop Science Ltd](https://www.sectoralpha.in/stocks/gsp-crop-science-ltd) ₹2,014 crore
6. [Titan Biotech Ltd](https://www.sectoralpha.in/stocks/titan-biotech-ltd) ₹1,755 crore
7. [Bharat Rasayan Ltd](https://www.sectoralpha.in/stocks/bharat-rasayan-ltd) ₹1,557 crore

[All 25 Pesticides/Agrochemicals companies, largest first](https://www.sectoralpha.in/sectors/pesticides-agrochemicals#all-companies)

### Companies close in size in other industries

1. [Nalwa Sons Investments Ltd](https://www.sectoralpha.in/stocks/nalwa-sons-investments-ltd) ₹2,542 crore · Finance & Investments - Others
2. [India Nippon Electricals Ltd](https://www.sectoralpha.in/stocks/india-nippon-electricals-ltd) ₹2,538 crore · Auto Ancillaries - Engine Parts
3. Bhagiradha Chemicals & Industries Ltd ₹2,533 crore
4. [Colab Platforms Ltd](https://www.sectoralpha.in/stocks/colab-platforms-ltd) ₹2,521 crore · IT Enabled Services/Business Process Outsourcing
5. [Marathon Nextgen Realty Ltd](https://www.sectoralpha.in/stocks/marathon-nextgen-realty-ltd) ₹2,517 crore · Realty - Regional

## What else do people ask about Bhagiradha Chemicals & Industries? ### What is Bhagiradha Chemicals & Industries's share price today? Bhagiradha Chemicals & Industries Ltd's share price is ₹187.19, −24.2% over the past year. The whole company is worth ₹2,432 Cr on the market. In the last 52 weeks it traded between ₹180 to ₹296; today it is 6% of the way up from the low, 24.8% below its 200-day average (as of 3 November 2026). ### What were Bhagiradha Chemicals & Industries's latest quarterly results? Bhagiradha Chemicals & Industries Ltd reported revenue of ₹195 Cr and net profit of ₹13.0 Cr for the Jun 2026 quarter. Revenue rose 57.3% and profit rose 225.0% compared with a year earlier. Earnings per share were ₹1.03 (as of 3 November 2026). ### What is Bhagiradha Chemicals & Industries's market cap? Bhagiradha Chemicals & Industries Ltd's market capitalisation is ₹2,432 Cr at a share price of ₹187.19. Market cap is the share price times the number of shares, so it changes whenever the price moves (as of 3 November 2026). ### How is Bhagiradha Chemicals & Industries performing? Bhagiradha Chemicals & Industries Ltd's share price has been falling for 2 weeks. In its latest quarter, revenue rose 57.3% and profit rose 225.0% compared with a year earlier. Over the past 13 weeks it has done worse than the NIFTY 500, for 10 weeks running (as of 3 November 2026). ### Will Bhagiradha Chemicals & Industries's share price go up? This page does not forecast Bhagiradha Chemicals & Industries Ltd's share price. What it shows instead: the share price is ₹187.19, and it has been falling for 2 weeks. Its P/E of 88.3× is higher than 53% of its own last 6 years (as of 3 November 2026). ### Who owns Bhagiradha Chemicals & Industries? Promoters own 19.6% of Bhagiradha Chemicals & Industries Ltd, foreign institutions 0.1%, domestic institutions 3.0% and the public 77.3% (latest quarter). No group of owners changed its stake by a full point over the last two years (as of 3 November 2026). ### Does Bhagiradha Chemicals & Industries have too much debt? Bhagiradha Chemicals & Industries Ltd has a moderate amount of debt: its debt is 0.34× its equity, and its operating profit is 3 times its interest bill. FY26 borrowings were ₹235 Cr against equity of ₹698 Cr. Keep that borrowing in mind when reading the returns on this page (as of 3 November 2026). ### Where is Bhagiradha Chemicals & Industries in its business cycle? Bhagiradha Chemicals & Industries Ltd's FY26 operating margin was 11.0%, against a 7-year range of 7.0% to 16.0%: the middle of its own range, neither a peak nor a low. The latest quarter was 16.0%. Comparing margins with a company's own long history is a good way to see where it is in its cycle (as of 3 November 2026). ### What could break the Bhagiradha Chemicals & Industries story? The main question: profits are rising, but only −14% of the last 3 years' profit came in as cash from operations. The gap between reported profit and actual cash is the thing to watch. On price, this page treats a rise as over when the share price closes below its 200-day average on two Fridays in a row (as of 3 November 2026). ### Is Bhagiradha Chemicals & Industries a stock worth studying right now? What the numbers show: Bhagiradha Chemicals & Industries Ltd's earnings have grown faster than its share price. Earnings per share grew +30.8% in a year while the price moved −24.2%. The main open question: whether the cash starts to follow the profit. Every number on this page is worked out by code from the published figures, with no forecasts and no price opinions (as of 3 November 2026). This is research, not advice. We’re not SEBI-registered.